Association between two functional polymorphisms of insulin-like growth factor binding protein 3 and colorectal cancer risk in a chinese population

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 72, Issue 11-12, 2009, Pages 706-711

  Xiang, Hao ^a   Liu, Li ^a   Chu, Guang Di ^a   Wei, Sheng ^a   Liu, Jian Ping ^b   Xu, Yi Hua ^a   Chen, Ji Gui ^c   Wang, Chong Jian ^d   Wei, Qing Yi ^e   Nie, Shao Fa ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c The Eighth Hospital of Wuhan   (China)

^d ZHENGZHOU UNIVERSITY   (China)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3;

AGED; ARTICLE; ASIAN; CASE CONTROL STUDY; CHINA; COLORECTAL TUMOR; EXON; FEMALE; GENETICS; HAPLOTYPE; HUMAN; MALE; MIDDLE AGED; MISSENSE MUTATION; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; COLORECTAL NEOPLASMS; EXONS; FEMALE; HAPLOTYPES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; MIDDLE AGED; MUTATION, MISSENSE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 67449108309     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390902841060     Document Type: Article

References (26)

1. Bustin, S. A., and Jenkins, P. J. 2001. The growth hormone-insulin-like growth factor-I axis and colorectal cancer. Trends Mol. Med. 7: 447-754.
2. Davies, M., Gupta, S., Goldspink, G., and Winslet M. 2006. The insulin-like growth factor system and colorectal cancer: Clinical and experimental evidence. Int. J. Colorectal Dis. 21:201-208.
3. Deal, C., Ma, J., Wilkin, F., Paquette, J., Rozen, F., Ge, B., Hudson, T., Stampfer, M., Pollak, M. 2001. Novel promoter polymorphism in insulinlike growth factor-binding protein-3: Correlation with serum levels and interaction with known regulators. J. Clin. Endocrinol. Metab. 86:1274-1280.
4. Firth, S. M., and Baxter, R. C. 2002. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23:824-854.
5. Fürstenberger, G., Morant, R., and Senn, H. J. 2002. Insulin-like growth factors and cancer. Lancet Oncol. 3:298-302.
6. Giovannucci, E., Pollak, M. N., Platz, E. A., Willett, W. C., Stampfer, M. J., Majeed, N., Colditz, G. A., Speizer, F. E., and Hankinson, S. E. 2000. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol. Biomarkers Prev. 9:345-349.
7. Grimberg S., and Cohen, P. 2000. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J. Cell Physiol. 183:1-9.
8. Harrela, M., Koistinen, H., Kaprio, J., Lehtovirta, M., Tuomilehto, J., Eriksson, J., Toivanen, L., Koskenvuo, M., Leinonen, P., Koistinen, R., and Seppälä, M. 1996. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J. Clin. Invest. 98:2612-2615.
9. Holmes, M. D., Pollak, M. N., and Hankinson, S. E. 2002. Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol. Biomarkers Prev. 11:862-867.
10. Imai, Y., Moralez, A., Andag, U., Clarke, J. B., Busby, W. H., Jr., and Clemmons, D. R. 2000. Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and-5 markedly reduce IGF-I binding and alter their biologic actions. J. Biol. Chem. 275:18188-18194.
11. Le Marchand, L., Kolonel, L.N., Henderson, B. E., and Wilkens, L. R. 2005. Association of an Exon 1 Polymorphism in the IGFBP3 gene with circulating IGFBP-3 levels and colorectal cancer risk: The multiethnic cohort study. Cancer Epidemiol. Biomarkers Prev. 14:1319-1321.
12. Li, L., Lu, F., and Zhang, W. 1997. Time trends in cancer mortality of recent twenty years in China and prediction in the near future. J. Chin. Cancer 19:3-9.
13. Li, C. P., Zhu, Y. J., Chen, R., Wu, W., Li, A. P., Liu, J., Liu, Q. Z., Wei, Q. Y., Zhang, Z. D., and Zhou, J. W. 2007. Functional polymorphisms of JWA gene are associated with risk of bladder cancer. J. Toxicol. Environ. Health A 70:876-884.
14. Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., and Stampfer, M. J. 1999. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. JNCI 91:620-625.
15. Morimoto, L. M., Newcomb, P. A., White, E., Bigler, J., and Potter, J. D. 2005a. Insulin-like growth factor polymorphisms and colorectal cancer risk. CancerEpidemiol. Biomarkers Prev. 14:1204-1211.
16. Morimoto, L.M., Newcomb, P.A., White, E., Bigler, J., Potter, J.D. 2005b. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: genetic factors. Cancer Epidemiol. Biomarkers Prev. 14:1394-1401.
17. Pechlivanis, S., Wagner, K., Chang-Claude, J., Hoffmeister, M., Brenner, H., and Försti, A. 2007. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer. Cancer Detect. Prev. 31:408-416.
18. Renehan, A. G., Zwahlen, M., Minder, C., O'Dwyer, S. T., Shalet, S. M., and Egger, M. 2004. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and meta-regression analysis. Lancet 363:1346-1353.
19. Ren, Z., Cai, Q., Shu, X. O., Cai, H., Li, C., Yu, H., et al. 2004. Genetic polymorphisms in the IGFBP3 gene: Association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women. Cancer Epidemiol. Biomarkers Prev. 13:1290-1295.
20. Roemer, H. C., Weistenhofer, W., Lohlein, D., Geller, F., Blomeke, B., and Golka, K. 2008. N-Acetyltransferase 1 in colon and rectal cancer cases from an industrialized area. J. Toxicol. Environ. Health A 71:902-905.
21. Sandhu, M. S., Dunger, D. B., and Giovannucci, E. L. 2002. Insulin, insulinlike growth factor-1 (IGF-1), IGF binding proteins, their biological interactions and colorectal cancer.JNCI 94:972-980.
22. Schernhammer, E. S., Hankinson, S. E., Hunter, D. J., Blouin, M. J., and Pollak, M. N. 2003. Polymorphic variation at the-202 locus in IGFBP3: influence on serum levelsof insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk. Int. J. Cancer 107:60-64.
23. Slattery, M. L., Samowitz, W., Curtin, K., Ma, K. N., Hoffman, M., Caan, B., and Neuhausen, S. 2004. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 13:1206-1214.
24. Stewart, C. E., and Rotwein, P. 1996. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol. Rev. 76:1005-1026.
25. Vorwerk, P., Yamanaka, Y., Spagnoli, A., Oh, Y., and Rosenfeld, R. G. 1998. Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine. J. Clin. Endocrinol. Metab. 83:1392-1395.
26. Yu, H., and Rohan, T. 2000. Role of the insulin-like growth factor family in cancer development and progression. JNCI 92:1472-1489.